clinic_doc

clinical-trials-day1

20

May2020
Clinical Trials Day is a special day to recognize the people who conduct clinical trials and thank them for improving public health. This day is also an opportunity to raise awareness about clinical trials. We'd like to thank and celebrate all clinical research professionals, including our very own at NRI, for ... Read More
May 20, 2020clinic_doc

11

May2020
We are excited to share some great work from Dr. Frias and the NRI team regarding Dulaglutide’s significant results tied to A1C and weight reduction in diabetes. We are so proud of the valuable results from of our involvement with this Eli Lilly study. https://medicaldialogues.in/diabetes-endocrinology/news/higher-doses-of-dulaglutide-reduces-blood-sugar-and-weight-in-diabetes-65621
May 11, 2020clinic_doc

07

May2020
Results showed a statistical significant reduction in liver fat in patients with NASH and diabetes. Our contribution to this important study is what makes us proud of what we do! https://www.businesswire.com/news/home/20200507005019/en/HighTide-Therapeutics-Announces-Positive-Topline-Results-Phase
May 7, 2020clinic_doc
Minie-Mercado2

28

Apr2020
She has conducted studies from Phase 1-4 for the past 25 years. Some of her experience expands CNS, Metabolic and Liver Disease. Prior to NRI, she was head of NASH research with a local Hepatology center. We are very excited to have her join our NRI team and help us ... Read More
April 28, 2020clinic_doc

12

Feb2020
February 12, 2020clinic_doc
metacrine

22

Jan2020
January 22, 2020clinic_doc
dr-frias-suit

02

Jan2020
January 2, 2020clinic_doc
dr-frias-contribution

23

Dec2019
December 23, 2019clinic_doc
NRI_Panorama-City_05DEC2019

08

Dec2019
December 8, 2019clinic_doc
drfrias

29

Nov2019
November 29, 2019clinic_doc
Our Response to COVID-19
X